United States regulatory notes for mineral ingredients
The United States sells magnesium bisglycinate as a dietary supplement, and the ingredient question is whether the form is a lawful dietary ingredient. Labelling, claims and contaminant limits sit in different rules, and the FDA does not approve a supplement or its label before sale. This note sets out the file a US buyer should expect. This is a sourcing reference, not legal advice.
Boundary
This is a sourcing reference, not legal advice. The destination market's current text and your regulatory team's sign-off decide the label.
Dietary ingredient basis
DSHEA, the 1994 amendment to the Federal Food, Drug and Cosmetic Act, defines a dietary supplement and its ingredients in section 201(ff). A magnesium chelate sold as a supplement rests on one of three bases: a new dietary ingredient notification filed at least 75 days before marketing, a GRAS conclusion, or evidence that the ingredient was marketed as a dietary supplement before 15 October 1994. The file should say which basis applies and hold the evidence for it.
No USP monograph
USP has no official monograph for magnesium bisglycinate, and the substance appears on USP's standards-in-development list rather than in the published compendium. Release testing therefore rests on the supplier's specification and on general chapters such as <731> loss on drying, <233> elemental impurities and <61>/<62> microbiological examination. A buyer who needs a compendial anchor has to write the specification rather than cite a monograph that does not exist.
Supplement Facts labelling
The Supplement Facts panel is set by 21 CFR 101.36, which requires the serving size, the amount of magnesium per serving as elemental magnesium and the percentage of the Daily Value. The Daily Value for magnesium is 420 mg for adults and children four years and older. The source line should read magnesium bisglycinate and match the ingredient named in the specification.
Structure/function claims
A structure/function claim describes the role of a nutrient in normal structure or function, and it must be truthful, not misleading and substantiated. The claim carries the DSHEA disclaimer required by 21 CFR 101.93, which states that the FDA has not evaluated the statement and that the product is not intended for any disease. The marketer must notify the FDA within 30 days of first marketing a product with such a claim, and disease claims are not permitted.
Contaminants and state law
There is no federal maximum level for lead in dietary supplements, and the cGMP rule in 21 CFR 111 sets process and identity requirements rather than metal limits. California's Proposition 65 supplies the exposure limits many US buyers work to: a maximum allowable dose level of 0.5 µg/day for lead and a no-significant-risk level of 15 µg/day. Exposure has to be calculated from the daily dose, so a mg/kg figure on its own does not answer the question.
cGMP and supplier qualification
21 CFR 111 requires identity testing of each component, supplier qualification, batch records and finished-product testing. For an imported ingredient, that means the buyer's own identity test on receipt, not only the supplier's certificate. The supplier's audit and specification file support that obligation but do not discharge it.
Documents to keep
- Dietary ingredient basis file: the NDI notification, the GRAS conclusion or the pre-1994 marketing evidence.
- Supplier specification and batch certificate of analysis with a named method for each parameter.
- Identity test record for the lot, covering magnesium, glycine and a phase or spectroscopic check.
- Heavy-metal report for lead, arsenic, cadmium and mercury with limits and quantification levels.
- Supplement Facts worksheet showing the 420 mg Daily Value and the elemental magnesium per serving.
- Structure/function claim file with substantiation, the DSHEA disclaimer and the 30-day FDA notification record.
Buyer checklist
- Confirm which dietary ingredient basis applies and keep the supporting file.
- Check that the form named in the Supplement Facts matches the form on the certificate of analysis.
- Check the 420 mg Daily Value and the % Daily Value arithmetic.
- Check the claim wording, the substantiation file and the DSHEA disclaimer, and diarise the 30-day FDA notification.
- Set a lead limit yourself, because no federal limit exists, and model the California Proposition 65 exposure from the daily dose.
- Confirm identity testing under 21 CFR 111, including a test on receipt.
- Check the rules of the states where the product will be sold, not only federal law.
Official sources
The product-specific position is on the magnesium bisglycinate compliance page. The tests behind the limits are on the ICP-MS page, and the document pack is described on the quality page.
Related documents
Send the destination market and the intended label. We will point to the framework and the documents the batch can carry.
Ask a regulatory question